Literature DB >> 2257519

Bone death in hip fracture in the elderly.

C R Dunstan1, R A Evans, E Hills, S Y Wong, R J Higgs.   

Abstract

We examined femoral head bone from 50 cadavers and from 21 patients who had suffered pathologic fracture of the femoral neck. We used a histochemical technique for lactate dehydrogenase (LDH) activity to demonstrate osteocyte viability. The femoral heads were removed within 36 hours of death or fracture, as LDH activity persists in the cytoplasm of viable cells for this time at 37 degrees after interruption of the blood supply. In the controls, there was an age-related reduction in mean osteocyte viability, from 88 +/- 7% (mean +/- SD) at age 10-29 years to 58 +/- 12% at age 70-89 years. In the hip fracture patients, mean osteocyte viability was 58 +/- 21% but there was much variability in both osteocyte viability and bone mass. In 5 fracture patients, there was extensive osteocyte death, suggesting that most of the femoral head bone was nonviable; these patients had little microfracture callus. Others had predominantly viable bone which was usually osteoporotic, and their bone frequently showed microfracture callus. Osteomalacia was not seen in any patient. It is suggested that bone death, in addition to osteoporosis, may sometimes contribute to hip fracture in the elderly.

Entities:  

Mesh:

Year:  1990        PMID: 2257519     DOI: 10.1007/bf02555908

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  16 in total

1.  Iliac crest trabecular bone volume as predictor for vertebral compressive strength, ash density and trabecular bone volume in normal individuals.

Authors:  L Mosekilde; L Mosekilde
Journal:  Bone       Date:  1988       Impact factor: 4.398

2.  Frequency of osteomalacia and osteoporosis in fractures of the proximal femur.

Authors:  J E Aaron; J C Gallagher; J Anderson; L Stasiak; E B Longton; B E Nordin; M Nicholson
Journal:  Lancet       Date:  1974-02-16       Impact factor: 79.321

3.  Evidence for two distinct syndromes of involutional osteoporosis.

Authors:  B L Riggs; L J Melton
Journal:  Am J Med       Date:  1983-12       Impact factor: 4.965

4.  Absence of metabolic bone disease in the proximal femur in patients with fracture of the femoral neck.

Authors:  M Wicks; R Garrett; B Vernon-Roberts; N Fazzalari
Journal:  J Bone Joint Surg Br       Date:  1982

5.  Experimental osteonecrosis of the femoral head in adult rabbits.

Authors:  J E Kenzora; R E Steele; Z H Yosipovitch; M J Glimcher
Journal:  Clin Orthop Relat Res       Date:  1978 Jan-Feb       Impact factor: 4.176

6.  Quantitative bone histology: a new method.

Authors:  C R Dunstan; R A Evans
Journal:  Pathology       Date:  1980-04       Impact factor: 5.306

Review 7.  Prevention of osteoporosis.

Authors:  R Lindsay
Journal:  Clin Orthop Relat Res       Date:  1987-09       Impact factor: 4.176

8.  The determination of bone viability: a histochemical method for identification of lactate dehydrogenase activity in osteocytes in fresh calcified and decalcified sections of human bone.

Authors:  S Y Wong; C R Dunstan; R A Evans; E Hills
Journal:  Pathology       Date:  1982-10       Impact factor: 5.306

9.  Mortality after hip fractures.

Authors:  J S Jensen; E Tøndevold
Journal:  Acta Orthop Scand       Date:  1979-04

10.  Bone density of the radius, spine, and proximal femur in osteoporosis.

Authors:  R B Mazess; H Barden; M Ettinger; E Schultz
Journal:  J Bone Miner Res       Date:  1988-02       Impact factor: 6.741

View more
  12 in total

Review 1.  Pathogenesis of postmenopausal osteoporosis.

Authors:  L G Raisz
Journal:  Rev Endocr Metab Disord       Date:  2001-01       Impact factor: 6.514

Review 2.  The past, present, and future of bone morphometry: its contribution to an improved understanding of bone biology.

Authors:  Webster S S Jee
Journal:  J Bone Miner Metab       Date:  2005       Impact factor: 2.626

Review 3.  Apoptosis in bone physiology and disease.

Authors:  D E Hughes; B F Boyce
Journal:  Mol Pathol       Date:  1997-06

Review 4.  Role of cortical bone in hip fracture.

Authors:  Jonathan Reeve
Journal:  Bonekey Rep       Date:  2017-01-13

Review 5.  Osteocyte death and hip fracture.

Authors:  C R Dunstan; N M Somers; R A Evans
Journal:  Calcif Tissue Int       Date:  1993       Impact factor: 4.333

Review 6.  Osteocyte apoptosis.

Authors:  Robert L Jilka; Brendon Noble; Robert S Weinstein
Journal:  Bone       Date:  2012-12-11       Impact factor: 4.398

Review 7.  Bone remodeling in hip fracture.

Authors:  J Reeve; J M Zanelli; N Garrahan; J N Bradbeer; J S Wand; S T Moyes; J P Roux; T Smith
Journal:  Calcif Tissue Int       Date:  1993       Impact factor: 4.333

8.  Transplantation of human umbilical cord blood-derived mesenchymal stem cells or their conditioned medium prevents bone loss in ovariectomized nude mice.

Authors:  Jee Hyun An; Hyojung Park; Jung Ah Song; Kyung Ho Ki; Jae-Yeon Yang; Hyung Jin Choi; Sun Wook Cho; Sang Wan Kim; Seong Yeon Kim; Jeong Joon Yoo; Wook-Young Baek; Jung-Eun Kim; Soo Jin Choi; Wonil Oh; Chan Soo Shin
Journal:  Tissue Eng Part A       Date:  2013-01-05       Impact factor: 3.845

9.  Sclerostin Immunoreactivity Increases in Cortical Bone Osteocytes and Decreases in Articular Cartilage Chondrocytes in Aging Mice.

Authors:  Michelle L Thompson; Juan Miguel Jimenez-Andrade; Patrick W Mantyh
Journal:  J Histochem Cytochem       Date:  2015-12-23       Impact factor: 2.479

10.  Mechanical induction of PGE2 in osteocytes blocks glucocorticoid-induced apoptosis through both the β-catenin and PKA pathways.

Authors:  Yukiko Kitase; Leonardo Barragan; Hai Qing; Shino Kondoh; Jean X Jiang; Mark L Johnson; Lynda F Bonewald
Journal:  J Bone Miner Res       Date:  2010-06-24       Impact factor: 6.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.